US 7374752
Reovirus for the treatment of cellular proliferative disorders
granted A61KA61K35/765A61K9/0019
Quick answer
US patent 7374752 (Reovirus for the treatment of cellular proliferative disorders) held by ONCOLYTICS BIOTECH INC. expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ONCOLYTICS BIOTECH INC.
- Grant date
- Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K35/765, A61K9/0019, A61P, A61P31/12